Total Credits: 1.0 including 1.0 AOA Category 1-A Credit(s)
The hepatitis C virus epidemic is uncontrolled in the United States, especially in the rural Pacific Northwest. Dr. Spencer describes results of a recent randomized trial of a peer-assisted telemedicine intervention to treat hepatitis C among rural people who use drugs. The rapid implementation of these findings into a large scale hepatitis C elimination program demonstrates opportunities for learners to apply novel hepatitis C elimination strategies in their communities.
Dr. Spencer has no actual or potential conflict of interest in relation to this program or presentation.
The Washington Osteopathic Medical Association is accredited by the American Osteopathic Association as a Category 1 CME Sponsor.
The WOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements.
Comments, questions, or complaints should be forwarded to WOMA Executive Director, Roseanne Andersen, by calling the WOMA office at 425-677-3930, by mail to WOMA, P.O. Box 1187, Gig Harbor, WA 98332, or by email to executivedirector@woma.org.
|
PPT Slide Notes
(1.4 MB)
PDF of PowerPoint with writable notes next to slides. |
Available after Purchase | ||
Dr. Spencer is a general internist and HIV specialist at Oregon Health & Science University, Hillsboro Medical Center in Hillsboro, Oregon. His mission is to create health equity through the elimination of chronic infectious diseases like Hepatitis C and HIV. A Washington native, he attended medical school at Pacific Northwest University of Health Sciences followed by Internal Medicine Residency with a distinction in Global Health from Oregon Health & Science University. Currently, he leads a novel HIV clinic, researches inequities related to PrEP and contributes to implementation of PATHS, a program eliminating Hepatitis C among rural Oregonians who inject drugs via peer-facilitated tele-health.
|
Coronary Artery Calcium Score: A Tool for Stratifying Cardiac Risk
Original Program Date: 06/07/2024 |
|
Glucagon-Like Peptide (GLP)-1 Agonists in Diabetes and Obesity: Management of Patients Taking GLP-1 Medications
Original Program Date: 06/08/2024 |
|
Climate Change and Health Effects of Climate Change on Inflammation, Allergy, and Autoimmune Disease
Original Program Date: 06/08/2024 |